DLPIC
SRNE

Davide Leone & Partners Investment Company’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-264,201
Closed -$2.19M – 116
2021
Q1 		$2.19M Buy
264,201
+59,430
+29% +$628K 0.27% 43
2020
Q4 		$1.4M Buy
+204,771
New +$1.64M 0.15% 81

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Davide Leone & Partners Investment Company's SRNE Position: Q2 2021 in Review

Davide Leone & Partners Investment Company sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2021, closing a stake of 264,201 shares — an estimated $2.19M sold.

Davide Leone & Partners Investment Company first reported a position in SRNE in Q4 2020 and held it in 2 quarters. The position peaked at $2.19M in Q1 2021. 212 funds tracked by Wall St. Rank hold SRNE as of Q2 2021.

  • Davide Leone & Partners Investment Company reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 264,201 Sorrento Therapeutics, Inc. shares in Q2 2021, an estimated $2.19M.
  • Davide Leone & Partners Investment Company first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 2 quarters.
  • Davide Leone & Partners Investment Company's Sorrento Therapeutics, Inc. position peaked at $2.19M in Q1 2021.
  • 212 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2021.

Based on Davide Leone & Partners Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.